CAN TTF1 STAINING BE USED AS SELECTION FOR EGFR-MUTATION ANALYSIS IN PATIENTS WITH LUNG CANCER?

被引：0

作者：

Vincenten, Julien ^{[1
]}

Smit, Egbert F. ^{[1
]}

Vos, Wim ^{[2
]}

Grunberg, Katrien ^{[2
]}

Postmus, Pieter E. ^{[3
]}

Heideman, Danielle ^{[4
]}

Snijders, Peter J. ^{[4
]}

Meijer, Gerrit A. ^{[4
]}

Kuik, Dirk J. ^{[2
]}

Thunnissen, Erik ^{[2
]}

机构：

[1] Vrije Univ Med Ctr, Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

[3] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands

[4] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

来源：

JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期

关键词：

lung carcinoma; TTF1; EGFR mutation; TRU;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S443 / S444

页数：2

共 50 条

[21] Clinical outcome of treatment with pemetrexed/cisplatin in patients with EGFR-mutation negative (EGFR-) metastatic non-small cell lung cancer (NSCLC)
Storozhakova, Anna E.
Vladimirova, Liubov Yu
Kit, Oleg Ivanovich
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[22] EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC).
Goldman, Jonathan Wade
Liu, Haiyan
Vuppalapaty, Meghah
Wilkerson, Charles
Lemaire, Clementine
Crouse, Steve
Sollier-Christen, Elodie
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[23] TTF1 negative in non small cell lung cancer adenocarcinoma: A prognostic factor.
Felipe Cordoba, Juan
Morales, Serafin
Veas Rodriguez, Joel
Rodriguez Galindo, Alvaro
Salud, Antonia
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[24] TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
Cordoba Ortega, J. F.
Salud, A.
Morales, S.
Veas, J.
Rodriguez, A.
ANNALS OF ONCOLOGY, 2019, 30
[25] Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression
Hosomi, Yukio
Tanai, Chiharu
Yoh, Kiyotaka
Goto, Yasushi
Sakai, Hiroshi
Kato, Terufumi
Kaburagi, Takayuki
Nishio, Makoto
Kim, Young Hak
Inoue, Akira
Hasegawa, Yoshinori
Isobe, Hiroshi
Tomizawa, Yoshio
Mori, Yoshiaki
Minato, Koichi
Yamada, Kazuhiko
Ohashi, Yasuo
Kunitoh, Hideo
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (10) : 1049 - 1056
[26] EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review
Enting, D.
Januszewski, A.
Benepal, T.
LUNG CANCER, 2012, 75 : S5 - S5
[27] A Multicenter Prospective Biomarker Study in Afatinib-Treated Patients with EGFR-Mutation Positive Non-Small Cell Lung Cancer
Azuma, Koichi
Iwama, Eiji
Sakai, Kazuko
Nozaki, Kaname
Harada, Daijiro
Hotta, Katsuyuki
Ohyanagi, Fumiyoshi
Kurata, Takayasu
Akamatsu, Hiroaki
Goto, Koichi
Fukuhara, Tatsuro
Nakanishi, Yoichi
Okamoto, Isamu
Nishio, Kazuto
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S299 - S299
[28] A multicenter prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung cancer
Iwama, E.
Sakai, K.
Azuma, K.
Nosaki, K.
Harada, D.
Hotta, K.
Ohyanagi, F.
Kurata, T.
Akamatsu, H.
Goto, K.
Fukuhara, T.
Nakanishi, Y.
Nishio, K.
Okamoto, I.
ANNALS OF ONCOLOGY, 2015, 26 : 148 - 149
[29] Analysis of 148 cases of EGFR mutation-positive lung cancer patients
Abe, Yuko
Tanio, Yoshiro
Shirai, Yuya
Mitui, Yuichi
Ogawa, Koichi
Akazawa, Yuki
Ueno, Kiyonobu
Oomori, Kenichi
Shimamoto, Shigetoshi
Fushimi, Hiroaki
ANNALS OF ONCOLOGY, 2016, 27
[30] EGFR MUTATION ANALYSIS IN SPUTUM OF LUNG CANCER PATIENTS: A MULTICENTER MULTITECHNIQUE STUDY
Hubers, A. Jasmijn
Heideman, Danielle A. M.
Yatabe, Yasushi
Wood, Michelle D.
Tull, Justyna
Taron, Miquel
Angel Molina-Vila, Miguel
Mayo, Clara
Bertran-Alamillo, Jordi
Herder, Gerarda J.
Koning, Remco
Sie, Daoud
Ylstra, Bauke
Meijer, Gerrit A.
Snijders, Peter J. F.
Witte, Birgit I.
Postmus, Pieter E.
Smit, Egbert F.
Thunnissen, Erik
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1285 - S1285

← 1 2 3 4 5 →